• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症研究的新时代。

The new era in cancer research.

作者信息

Varmus Harold

机构信息

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Science. 2006 May 26;312(5777):1162-5. doi: 10.1126/science.1126758.

DOI:10.1126/science.1126758
PMID:16728627
Abstract

For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and (especially) treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.

摘要

多年来,有关癌症遗传决定因素的发现似乎对临床控制该疾病的努力仅产生了微小影响。然而,随着过去十年取得的进展,用分子术语描述癌症似乎越来越有可能改善人类癌症的检测、分类、监测以及(尤其是)治疗方式。要实现癌症研究这一新时代的医学前景,需要更深入地了解癌症生物学,并在临床上富有想象力地应用新知识,同时还需要政治、社会和文化变革。

相似文献

1
The new era in cancer research.癌症研究的新时代。
Science. 2006 May 26;312(5777):1162-5. doi: 10.1126/science.1126758.
2
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.《2007年临床癌症进展:癌症治疗、预防及筛查的重大研究进展——美国临床肿瘤学会报告》
J Clin Oncol. 2008 Jan 10;26(2):313-25. doi: 10.1200/JCO.2007.15.4088. Epub 2007 Dec 17.
3
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2013:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2014 Jan 10;32(2):129-60. doi: 10.1200/JCO.2013.53.7076. Epub 2013 Dec 10.
4
What is the future of oncology? National Cancer Institute initiatives to improve research, development, and implementation in cancer prevention and treatment.肿瘤学的未来是什么?美国国立癌症研究所改善癌症预防与治疗研究、开发及实施的举措。
Semin Oncol. 2006 Dec;33(6 Suppl 11):S6-9. doi: 10.1053/j.seminoncol.2006.10.012.
5
Surgical oncology research development: the perspective of the National Cancer Institute.外科肿瘤学研究进展:美国国立癌症研究所的视角
Cancer Treat Rep. 1984 Jun;68(6):825-9.
6
A new era for cancer prevention and control research.癌症预防与控制研究的新时代。
Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):955-6.
7
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.《2009年临床癌症进展:癌症治疗、预防及筛查方面的重大研究进展——美国临床肿瘤学会报告》
J Clin Oncol. 2009 Dec 10;27(35):6052-69. doi: 10.1200/JCO.2009.26.6171. Epub 2009 Nov 9.
8
Winning the cancer fight: a look at the future.战胜癌症:展望未来。
Prim Care. 2009 Dec;36(4):859-65; table of contents. doi: 10.1016/j.pop.2009.07.003.
9
Research funding. NIH in the post-doubling era: realities and strategies.研究经费。后翻倍时代的美国国立卫生研究院:现实与策略。
Science. 2006 Nov 17;314(5802):1088-90. doi: 10.1126/science.1136931.
10
Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research.美国国立癌症研究所的科学管理:癌基因研究中的认知与机遇
Cancer Res. 1984 Oct;44(10):4693-6.

引用本文的文献

1
Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review.作为潜在药理实体的非稠合嘧啶衍生物:综述
Curr Top Med Chem. 2025;25(9):1032-1068. doi: 10.2174/0115680266317088240924205745.
2
Synthesis and Biological Evaluation of Novel Furopyridone Derivatives as Potent Cytotoxic Agents against Esophageal Cancer.新型呋喃并吡啶酮衍生物的合成及作为有效抗食管癌细胞毒剂的生物学评价。
Int J Mol Sci. 2024 Sep 5;25(17):9634. doi: 10.3390/ijms25179634.
3
Life history traits and cancer prevalence in birds.鸟类的生活史特征与癌症患病率
Evol Med Public Health. 2024 Jun 27;12(1):105-116. doi: 10.1093/emph/eoae011. eCollection 2024.
4
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis.与4-甲基磺酰基苯基支架相连的新型吡唑啉的合成、酶抑制测定及分子模拟研究:抗肿瘤活性和细胞周期分析
RSC Adv. 2024 Jul 12;14(31):22132-22146. doi: 10.1039/d4ra03902e.
5
QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-]pyridine Derivatives.基于咪唑并[4,5-]吡啶衍生物的极光激酶抑制剂的定量构效关系研究、分子对接及分子动力学模拟
Molecules. 2024 Apr 13;29(8):1772. doi: 10.3390/molecules29081772.
6
Design, synthesis, molecular modelling and biological evaluation of novel 6-amino-5-cyano-2-thiopyrimidine derivatives as potent anticancer agents against leukemia and apoptotic inducers.新型 6-氨基-5-氰基-2-嘧啶硫酮衍生物的设计、合成、分子模拟及作为白血病潜在抗癌剂和凋亡诱导剂的生物学评价。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2304625. doi: 10.1080/14756366.2024.2304625. Epub 2024 Feb 13.
7
Design, synthesis, studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers.新型嘧啶-5-腈衍生物作为潜在抗增殖剂、VEGFR-2抑制剂和凋亡诱导剂的设计、合成、研究及生物学评价
RSC Adv. 2023 Jul 24;13(32):22122-22147. doi: 10.1039/d3ra04182d. eCollection 2023 Jul 19.
8
Life history and cancer in birds: clutch size predicts cancer.鸟类的生活史与癌症:窝卵数可预测癌症。
bioRxiv. 2023 Feb 13:2023.02.11.528100. doi: 10.1101/2023.02.11.528100.
9
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and study.新型苯并噻唑类杂合体作为潜在的 VEGFR-2 抑制剂:设计、合成、抗癌评价及研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2166036. doi: 10.1080/14756366.2023.2166036.
10
Rational synthesis, anticancer activity, and molecular docking studies of novel benzofuran liked thiazole hybrids.新型苯并呋喃类似噻唑杂合体的合理合成、抗癌活性及分子对接研究。
Mol Divers. 2023 Jun;27(3):1345-1357. doi: 10.1007/s11030-022-10493-7. Epub 2022 Jul 19.